4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-7-methoxyquinolin-6-yl 4-aminobenzoate

ID: ALA5290660

Chembl Id: CHEMBL5290660

Max Phase: Preclinical

Molecular Formula: C34H27FN4O6

Molecular Weight: 606.61

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC(=O)c1ccc(N)cc1

Standard InChI:  InChI=1S/C34H27FN4O6/c1-43-29-19-27-26(18-30(29)45-31(40)20-2-6-22(36)7-3-20)28(14-17-37-27)44-25-12-10-24(11-13-25)39-33(42)34(15-16-34)32(41)38-23-8-4-21(35)5-9-23/h2-14,17-19H,15-16,36H2,1H3,(H,38,41)(H,39,42)

Standard InChI Key:  SCRLASBTYTZCKB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5290660

    ---

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 606.61Molecular Weight (Monoisotopic): 606.1915AlogP: 6.33#Rotatable Bonds: 9
Polar Surface Area: 141.87Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.46CX Basic pKa: 5.79CX LogP: 5.65CX LogD: 5.64
Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.08Np Likeness Score: -0.65

References

1. Van de Walle T, Cools L, Mangelinckx S, D'hooghe M..  (2021)  Recent contributions of quinolines to antimalarial and anticancer drug discovery research.,  226  [PMID:34655985] [10.1016/j.ejmech.2021.113865]

Source